Crescent Biopharma issues pre-funded warrants for 525,897 shares in $143.7 million offering
CBIO•Public offering details
Crescent Biopharma closed a public offering that included issuance of pre-funded warrants to buy up to 525,897 ordinary shares.
Pre-funded warrants were priced at $14.499 each, reflecting a $0.001 per-share exercise price.
The offering also sold 9,387,896 ordinary shares at $14.5 each, for gross proceeds of about $143.7 million.
